Molecular Determinants and Genetic Modifiers of Aggregation and Toxicity for the ALS Disease Protein FUS/TLS
2011
A Yeast Model for Understanding ALS
publication
Evidence: moderate
Author Information
Author(s): Zhihui Sun, Zamia Diaz, James Shorter, Aaron Gitler, Shulin Ju, Gregory Petsko, Dagmar Ringe
Hypothesis
Can yeast models help us understand the mechanisms of ALS related to the FUS protein?
Conclusion
The studies suggest that defects in RNA processing and transport may be central to ALS pathophysiology.
Supporting Evidence
- Both studies found that restricting overexpressed wild-type FUS to the nucleus mitigated its toxic effect.
- Purified FUS is more prone to aggregation than purified TDP-43.
- Genome-wide screens identified genes that mitigate ALS-linked toxicity.
Takeaway
Scientists used yeast to study a protein linked to ALS, finding that how the protein behaves could help us understand the disease better.
Methodology
The studies involved overexpressing human FUS in yeast and conducting genome-wide screens to identify genes that mitigate toxicity.
Limitations
The studies were conducted in yeast, which may not fully replicate human disease mechanisms.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website